Pfizer to Acquire Trillium Therapeutics Inc

British Reporter — Pfizer Inc and Trillium Therapeutics Inc.  today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms

More
6 mins read